CapLaw-2025-50

On 26 May 2025, DocMorris AG settled on its rights offering with gross proceeds of CHF 208 million. The proceeds will be used to finance the planned medium-term growth in the prescription medicines (Rx) business, including incrementally targeted Rx marketing spend, as well as a potential repayment of the CHF 95 million convertible bond in September…